MK 1775
| CAS No. | 955365-80-7 |
|---|---|
| MDL No. | MFCD17215200 |
| MF | C27H32N8O2 |
| MW | 500.60 |
| InChI Key | BKWJAKQVGHWELA-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Adavosertib is a pyrazolopyrimidine compound with the structure of 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one substituted at positions 1, 2, and 6 by 6-(2-hydroxypropan-2-yl)pyridin-2-yl, prop-1-en-3-yl, and [4-(4-methylpiperazin-1-yl)phenyl]amino groups, respectively. It is a potent and selective oral inhibitor of WEE1 kinase, functioning as an antineoplastic agent and an inhibitor of EC 2.7.11.1 (non-specific serine/threonine protein kinase). It belongs to the classes of pyridines, tertiary alcohols, secondary amino compounds, N-arylpiperazines, and N-methylpiperazines.
| CAS No. | 955365-80-7 |
|---|---|
| Product Name | MK 1775 |
Biological Targets
WEE1
Associated Conditions
neuroblastoma·head and neck squamous cell carcinoma·non-small cell lung carcinoma·ovarian carcinoma·breast cancer·
* The information provided here is compiled from public sources and is for reference only.
